VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q42627977 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233140.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q42627977‏
024 ‎‡a 0000-0001-9017-3922‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q42627977‏
100 0 ‎‡a Regina H Silva‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Regina H Silva‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Regina H Silva‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A rodent model of appetitive discrimination with concomitant evaluation of anxiety-like behavior‏
670 ‎‡a Author's Amnestic effect of cocaine after the termination of its stimulant action.‏
670 ‎‡a Author's Antidepressants differentially modify the extinction of an aversive memory task in female rats.‏
670 ‎‡a Author's Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice‏
670 ‎‡a Author's Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice‏
670 ‎‡a Author's Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms‏
670 ‎‡a Author's Basolateral amygdala inactivation impairs learned‏
670 ‎‡a Author's Basolateral amygdala inactivation impairs learned (but not innate) fear response in rats‏
670 ‎‡a Author's Behavioral characterization of morphine effects on motor activity in mice.‏
670 ‎‡a Author's Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity.‏
670 ‎‡a Author's Bovine brain phosphatidylserine attenuates scopolamine-induced amnesia.‏
670 ‎‡a Author's Bovine brain phosphatidylserine attenuates scopolamine induced amnesia in mice.‏
670 ‎‡a Author's CA1 inactivation impairs episodic-like memory in rats‏
670 ‎‡a Author's Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?‏
670 ‎‡a Author's Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats‏
670 ‎‡a Author's Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.‏
670 ‎‡a Author's Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice‏
670 ‎‡a Author's Deltamethrin Intranasal administration induces memory, emotional and tyrosine hydroxylase immunoreactivity alterations in rats‏
670 ‎‡a Author's Diazepam effects on aversive memory retrieval and extinction: Role of anxiety levels‏
670 ‎‡a Author's Differential Cortical c-Fos and Zif-268 Expression after Object and Spatial Memory Processing in a Standard or Episodic-Like Object Recognition Task.‏
670 ‎‡a Author's Differential roles of the dorsal hippocampal regions in the acquisition of spatial and temporal aspects of episodic-like memory‏
670 ‎‡a Author's Drug-induced home cage conspecifics' behavior can potentiate behavioral sensitization in mice.‏
670 ‎‡a Author's Effect of ganglioside‏
670 ‎‡a Author's Effect of ganglioside (GM1) on memory in senescent rats.‏
670 ‎‡a Author's Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice‏
670 ‎‡a Author's Effects of amphetamine on the plus-maze discriminative avoidance task in mice‏
670 ‎‡a Author's Effects of baclofen on reserpine-induced vacuous chewing movements in mice.‏
670 ‎‡a Author's Effects of gabaergic drugs on reserpine-induced oral dyskinesia.‏
670 ‎‡a Author's Effects of long-term continuous exposure to light on memory and anxiety in mice.‏
670 ‎‡a Author's Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice.‏
670 ‎‡a Author's Effects of monosialoganglioside GM1 on scopolamine-induced amnesia.‏
670 ‎‡a Author's Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning.‏
670 ‎‡a Author's Effects of neonatal GM1 administration on the discriminative avoidance behavior of adult rats.‏
670 ‎‡a Author's Effects of pre- or post-training paradoxical sleep deprivation on two animal models of learning and memory in mice‏
670 ‎‡a Author's Effects of reserpine on the plus-maze discriminative avoidance task: dissociation between memory and motor impairments‏
670 ‎‡a Author's Effects of social isolation on aging-induced orofacial movements in rats‏
670 ‎‡a Author's Effects of topiramate on oral dyskinesia induced by reserpine.‏
670 ‎‡a Author's Effects of valproic acid on an animal model of tardive dyskinesia.‏
670 ‎‡a Author's Extending possible applications of an episodic-like memory task in rats‏
670 ‎‡a Author's Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice.‏
670 ‎‡a Author's Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review‏
670 ‎‡a Author's Hatha Yoga practice decreases menopause symptoms and improves quality of life: A randomized controlled trial.‏
670 ‎‡a Author's Hippocampal-dependent memory in the plus-maze discriminative avoidance task: The role of spatial cues and CA1 activity‏
670 ‎‡a Author's Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia.‏
670 ‎‡a Author's Improvement in physiological and psychological parameters after 6 months of yoga practice‏
670 ‎‡a Author's Long-term haloperidol treatment‏
670 ‎‡a Author's Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors‏
670 ‎‡a Author's Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease‏
670 ‎‡a Author's Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model‏
670 ‎‡a Author's Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice‏
670 ‎‡a Author's Paradoxical sleep deprivation impairs acquisition, consolidation, and retrieval of a discriminative avoidance task in rats‏
670 ‎‡a Author's Passiflora cincinnata Extract Delays the Development of Motor Signs and Prevents Dopaminergic Loss in a Mice Model of Parkinson's Disease‏
670 ‎‡a Author's Pharmacological characterization of crotamine effects on mice hind limb paralysis employing both ex vivo and in vivo assays: Insights into the involvement of voltage-gated ion channels in the crotamine action on skeletal muscles‏
670 ‎‡a Author's Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.‏
670 ‎‡a Author's Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease.‏
670 ‎‡a Author's Role of anxiety levels in memory performance of spontaneously hypertensive rats.‏
670 ‎‡a Author's Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice‏
670 ‎‡a Author's Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.‏
670 ‎‡a Author's Sex differences in aversive memory in rats: possible role of extinction and reactive emotional factors‏
670 ‎‡a Author's Sleep deprivation abolishes the locomotor stimulant effect of ethanol in mice‏
670 ‎‡a Author's Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression‏
670 ‎‡a Author's Subtle Alterations in Spatial Memory Induced by Amyloid Peptides Infusion in Rats.‏
670 ‎‡a Author's The importance of housing conditions on behavioral sensitization and tolerance to ethanol‏
670 ‎‡a Author's The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine.‏
670 ‎‡a Author's Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.‏
909 ‎‡a (orcid) 0000000190173922‏ ‎‡9 1‏
919 ‎‡a plusmazediscriminativeavoidancetaskanewmodeltostudymemoryanxietyinteractionseffectsofchlordiazepoxideandcaffeine‏ ‎‡A The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine.‏ ‎‡9 1‏
919 ‎‡a importanceofhousingconditionsonbehavioralsensitizationandtolerancetoethanol‏ ‎‡A The importance of housing conditions on behavioral sensitization and tolerance to ethanol‏ ‎‡9 1‏
919 ‎‡a subtlealterationsinspatialmemoryinducedbyamyloidpeptidesinfusioninrats‏ ‎‡A Subtle Alterations in Spatial Memory Induced by Amyloid Peptides Infusion in Rats.‏ ‎‡9 1‏
919 ‎‡a spontaneouslyhypertensiveratsshrareresistanttoareserpineinducedprogressivemodelofparkinsonsdiseasedifferencesinmotorbehaviortyrosinehydroxylaseandαsynucleinexpression‏ ‎‡A Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression‏ ‎‡9 1‏
919 ‎‡a sleepdeprivationabolishesthelocomotorstimulanteffectofethanolinmice‏ ‎‡A Sleep deprivation abolishes the locomotor stimulant effect of ethanol in mice‏ ‎‡9 1‏
919 ‎‡a sexdifferencesinaversivememoryinratspossibleroleofextinctionandreactiveemotionalfactors‏ ‎‡A Sex differences in aversive memory in rats: possible role of extinction and reactive emotional factors‏ ‎‡9 1‏
919 ‎‡a roleoflearningofopenarmavoidanceinthephenomenonof1trialtolerancetotheanxiolyticeffectofchlordiazepoxideinmice‏ ‎‡A Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.‏ ‎‡9 1‏
919 ‎‡a roleofhippocampaloxidativestressinmemorydeficitsinducedbysleepdeprivationinmice‏ ‎‡A Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice‏ ‎‡9 1‏
919 ‎‡a roleofanxietylevelsinmemoryperformanceofspontaneouslyhypertensiverats‏ ‎‡A Role of anxiety levels in memory performance of spontaneously hypertensive rats.‏ ‎‡9 1‏
919 ‎‡a repeatedtreatmentwithalowdoseofreserpineasaprogressivemodelofparkinsonsdisease‏ ‎‡A Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease.‏ ‎‡9 1‏
919 ‎‡a pretraininganandamideinfusionwithinthebasolateralamygdalaimpairsplusmazediscriminativeavoidancetaskinrats‏ ‎‡A Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.‏ ‎‡9 1‏
919 ‎‡a pharmacologicalcharacterizationofcrotamineeffectsonmicehindlimbparalysisemployingbothexvivoandinvivoassaysinsightsintotheinvolvementofvoltagegatedionchannelsinthecrotamineactiononskeletalmuscles‏ ‎‡A Pharmacological characterization of crotamine effects on mice hind limb paralysis employing both ex vivo and in vivo assays: Insights into the involvement of voltage-gated ion channels in the crotamine action on skeletal muscles‏ ‎‡9 1‏
919 ‎‡a passifloracincinnataextractdelaysthedevelopmentofmotorsignsandpreventsdopaminergiclossinamicemodelofparkinsonsdisease‏ ‎‡A Passiflora cincinnata Extract Delays the Development of Motor Signs and Prevents Dopaminergic Loss in a Mice Model of Parkinson's Disease‏ ‎‡9 1‏
919 ‎‡a paradoxicalsleepdeprivationimpairsacquisitionconsolidationandretrievalofadiscriminativeavoidancetaskinrats‏ ‎‡A Paradoxical sleep deprivation impairs acquisition, consolidation, and retrieval of a discriminative avoidance task in rats‏ ‎‡9 1‏
919 ‎‡a naltrexonepotentiatesbothamnesticandanxiolyticeffectsofchlordiazepoxideinmice‏ ‎‡A Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice‏ ‎‡9 1‏
919 ‎‡a molecularneurochemicalandbehavioralhallmarksofreserpineasamodelforparkinsonsdiseasenewperspectivestoalongstandingmodel‏ ‎‡A Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model‏ ‎‡9 1‏
919 ‎‡a memoryimpairmentinducedbylowdosesofreserpineinratspossiblerelationshipwithemotionalprocessingdeficitsinparkinsondisease‏ ‎‡A Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease‏ ‎‡9 1‏
919 ‎‡a longtermhaloperidoltreatmentbutnotrisperidoneenhancesaddictionrelatedbehaviorsinmiceroleofdopamined2receptors‏ ‎‡A Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors‏ ‎‡9 1‏
919 ‎‡a longtermhaloperidoltreatment‏ ‎‡A Long-term haloperidol treatment‏ ‎‡9 1‏
919 ‎‡a improvementinphysiologicalandpsychologicalparametersafter6monthsofyogapractice‏ ‎‡A Improvement in physiological and psychological parameters after 6 months of yoga practice‏ ‎‡9 1‏
919 ‎‡a importantroleofstriatalcatalaseinagingandreserpineinducedoraldyskinesia‏ ‎‡A Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia.‏ ‎‡9 1‏
919 ‎‡a hippocampaldependentmemoryintheplusmazediscriminativeavoidancetasktheroleofspatialcuesandca1activity‏ ‎‡A Hippocampal-dependent memory in the plus-maze discriminative avoidance task: The role of spatial cues and CA1 activity‏ ‎‡9 1‏
919 ‎‡a hathayogapracticedecreasesmenopausesymptomsandimprovesqualityoflifearandomizedcontrolledtrial‏ ‎‡A Hatha Yoga practice decreases menopause symptoms and improves quality of life: A randomized controlled trial.‏ ‎‡9 1‏
919 ‎‡a geneticvariantsinsncaandtheriskofsporadicparkinsonsdiseaseandclinicaloutcomesareview‏ ‎‡A Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review‏ ‎‡9 1‏
919 ‎‡a gangliosidegm1attenuatesscopolamineinducedamnesiainratsandmice‏ ‎‡A Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice.‏ ‎‡9 1‏
919 ‎‡a extendingpossibleapplicationsofanepisodiclikememorytaskinrats‏ ‎‡A Extending possible applications of an episodic-like memory task in rats‏ ‎‡9 1‏
919 ‎‡a effectsofvalproicacidonananimalmodeloftardivedyskinesia‏ ‎‡A Effects of valproic acid on an animal model of tardive dyskinesia.‏ ‎‡9 1‏
919 ‎‡a effectsoftopiramateonoraldyskinesiainducedbyreserpine‏ ‎‡A Effects of topiramate on oral dyskinesia induced by reserpine.‏ ‎‡9 1‏
919 ‎‡a effectsofsocialisolationonaginginducedorofacialmovementsinrats‏ ‎‡A Effects of social isolation on aging-induced orofacial movements in rats‏ ‎‡9 1‏
919 ‎‡a effectsofreserpineontheplusmazediscriminativeavoidancetaskdissociationbetweenmemoryandmotorimpairments‏ ‎‡A Effects of reserpine on the plus-maze discriminative avoidance task: dissociation between memory and motor impairments‏ ‎‡9 1‏
919 ‎‡a effectsofpreorposttrainingparadoxicalsleepdeprivationon2animalmodelsoflearningandmemoryinmice‏ ‎‡A Effects of pre- or post-training paradoxical sleep deprivation on two animal models of learning and memory in mice‏ ‎‡9 1‏
919 ‎‡a effectsofneonatalgm1administrationonthediscriminativeavoidancebehaviorofadultrats‏ ‎‡A Effects of neonatal GM1 administration on the discriminative avoidance behavior of adult rats.‏ ‎‡9 1‏
919 ‎‡a effectsofmorphineontheplusmazediscriminativeavoidancetaskroleofstatedependentlearning‏ ‎‡A Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning.‏ ‎‡9 1‏
919 ‎‡a effectsofmonosialogangliosidegm1onscopolamineinducedamnesia‏ ‎‡A Effects of monosialoganglioside GM1 on scopolamine-induced amnesia.‏ ‎‡9 1‏
919 ‎‡a effectsoflongtermgangliosidegm1administrationonanewdiscriminativeavoidancetestinnormaladultmice‏ ‎‡A Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice.‏ ‎‡9 1‏
919 ‎‡a effectsoflongtermcontinuousexposuretolightonmemoryandanxietyinmice‏ ‎‡A Effects of long-term continuous exposure to light on memory and anxiety in mice.‏ ‎‡9 1‏
919 ‎‡a effectsofgabaergicdrugsonreserpineinducedoraldyskinesia‏ ‎‡A Effects of gabaergic drugs on reserpine-induced oral dyskinesia.‏ ‎‡9 1‏
919 ‎‡a effectsofbaclofenonreserpineinducedvacuouschewingmovementsinmice‏ ‎‡A Effects of baclofen on reserpine-induced vacuous chewing movements in mice.‏ ‎‡9 1‏
919 ‎‡a effectsofamphetamineontheplusmazediscriminativeavoidancetaskinmice‏ ‎‡A Effects of amphetamine on the plus-maze discriminative avoidance task in mice‏ ‎‡9 1‏
919 ‎‡a effectsof3nitropropionicacidadministrationonmemoryandhippocampallipidperoxidationinsleepdeprivedmice‏ ‎‡A Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice‏ ‎‡9 1‏
919 ‎‡a effectofgangliosidegm1onmemoryinsenescentrats‏ ‎‡A Effect of ganglioside (GM1) on memory in senescent rats.‏ ‎‡9 1‏
919 ‎‡a effectofganglioside‏ ‎‡A Effect of ganglioside‏ ‎‡9 1‏
919 ‎‡a druginducedhomecageconspecificsbehaviorcanpotentiatebehavioralsensitizationinmice‏ ‎‡A Drug-induced home cage conspecifics' behavior can potentiate behavioral sensitization in mice.‏ ‎‡9 1‏
919 ‎‡a differentialrolesofthedorsalhippocampalregionsintheacquisitionofspatialandtemporalaspectsofepisodiclikememory‏ ‎‡A Differential roles of the dorsal hippocampal regions in the acquisition of spatial and temporal aspects of episodic-like memory‏ ‎‡9 1‏
919 ‎‡a variantsinsncageneareassociatedwithparkinsonsdiseaseriskandcognitivesymptomsinabraziliansample‏ ‎‡A Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.‏ ‎‡9 1‏
919 ‎‡a rodentmodelofappetitivediscriminationwithconcomitantevaluationofanxietylikebehavior‏ ‎‡A A rodent model of appetitive discrimination with concomitant evaluation of anxiety-like behavior‏ ‎‡9 1‏
919 ‎‡a amnesticeffectofcocaineaftertheterminationofitsstimulantaction‏ ‎‡A Amnestic effect of cocaine after the termination of its stimulant action.‏ ‎‡9 1‏
919 ‎‡a antidepressantsdifferentiallymodifytheextinctionofanaversivememorytaskinfemalerats‏ ‎‡A Antidepressants differentially modify the extinction of an aversive memory task in female rats.‏ ‎‡9 1‏
919 ‎‡a antidyskineticeffectsofrisperidoneonanimalmodelsoftardivedyskinesiainmice‏ ‎‡A Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice‏ ‎‡9 1‏
919 ‎‡a anxiogeniceffectofsleepdeprivationintheelevatedplusmazetestinmice‏ ‎‡A Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice‏ ‎‡9 1‏
919 ‎‡a associationofbdnfval66metpolymorphismwithparkinsonsdiseaseanddepressionandanxietysymptoms‏ ‎‡A Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms‏ ‎‡9 1‏
919 ‎‡a basolateralamygdalainactivationimpairslearned‏ ‎‡A Basolateral amygdala inactivation impairs learned‏ ‎‡9 1‏
919 ‎‡a basolateralamygdalainactivationimpairslearnedbutnotinnatefearresponseinrats‏ ‎‡A Basolateral amygdala inactivation impairs learned (but not innate) fear response in rats‏ ‎‡9 1‏
919 ‎‡a behavioralcharacterizationofmorphineeffectsonmotoractivityinmice‏ ‎‡A Behavioral characterization of morphine effects on motor activity in mice.‏ ‎‡9 1‏
919 ‎‡a beneficialeffectsofvitamin100andvitamineonreserpineinducedoraldyskinesiainratscriticalroleofstriatalcatalaseactivity‏ ‎‡A Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity.‏ ‎‡9 1‏
919 ‎‡a bovinebrainphosphatidylserineattenuatesscopolamineinducedamnesia‏ ‎‡A Bovine brain phosphatidylserine attenuates scopolamine-induced amnesia.‏ ‎‡9 1‏
919 ‎‡a bovinebrainphosphatidylserineattenuatesscopolamineinducedamnesiainmice‏ ‎‡A Bovine brain phosphatidylserine attenuates scopolamine induced amnesia in mice.‏ ‎‡9 1‏
919 ‎‡a ca1inactivationimpairsepisodiclikememoryinrats‏ ‎‡A CA1 inactivation impairs episodic-like memory in rats‏ ‎‡9 1‏
919 ‎‡a cannabidiolasapromisingstrategytotreatandpreventmovementdisorders‏ ‎‡A Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?‏ ‎‡9 1‏
919 ‎‡a cannabidiolpreventsmotorandcognitiveimpairmentsinducedbyreserpineinrats‏ ‎‡A Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats‏ ‎‡9 1‏
919 ‎‡a carvacrolpreventsimpairmentsinmotorandneurochemicalparametersinamodelofprogressiveparkinsonisminducedbyreserpine‏ ‎‡A Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.‏ ‎‡9 1‏
919 ‎‡a concomitantdevelopmentoforaldyskinesiaandmemorydeficitsinreserpinetreatedmaleandfemalemice‏ ‎‡A Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice‏ ‎‡9 1‏
919 ‎‡a deltamethrinintranasaladministrationinducesmemoryemotionalandtyrosinehydroxylaseimmunoreactivityalterationsinrats‏ ‎‡A Deltamethrin Intranasal administration induces memory, emotional and tyrosine hydroxylase immunoreactivity alterations in rats‏ ‎‡9 1‏
919 ‎‡a diazepameffectsonaversivememoryretrievalandextinctionroleofanxietylevels‏ ‎‡A Diazepam effects on aversive memory retrieval and extinction: Role of anxiety levels‏ ‎‡9 1‏
919 ‎‡a differentialcortical100fosandzif268expressionafterobjectandspatialmemoryprocessinginastandardorepisodiclikeobjectrecognitiontask‏ ‎‡A Differential Cortical c-Fos and Zif-268 Expression after Object and Spatial Memory Processing in a Standard or Episodic-Like Object Recognition Task.‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000449641327‏
996 ‎‡2 BLBNB|000502127‏
996 ‎‡2 BLBNB|001465018‏
996 ‎‡2 LC|n 2004012972‏
996 ‎‡2 DNB|170789632‏
996 ‎‡2 BLBNB|000240677‏
996 ‎‡2 PTBNP|178420‏
996 ‎‡2 PTBNP|1372940‏
996 ‎‡2 RERO|A020068985‏
996 ‎‡2 ISNI|0000000060588660‏
996 ‎‡2 ISNI|0000000073422416‏
996 ‎‡2 PLWABN|9812830222905606‏
996 ‎‡2 BLBNB|001505482‏
996 ‎‡2 J9U|987007357399205171‏
996 ‎‡2 PTBNP|1366179‏
996 ‎‡2 ISNI|0000000033007234‏
996 ‎‡2 PTBNP|114835‏
996 ‎‡2 BLBNB|000303101‏
996 ‎‡2 ISNI|0000000042044651‏
996 ‎‡2 DNB|1048644944‏
996 ‎‡2 BLBNB|001465364‏
996 ‎‡2 BLBNB|000325386‏
996 ‎‡2 SUDOC|082943346‏
996 ‎‡2 DNB|1255102365‏
996 ‎‡2 NTA|138932085‏
996 ‎‡2 LC|n 84182342‏
996 ‎‡2 NTA|330621696‏
996 ‎‡2 ISNI|0000000119729975‏
996 ‎‡2 CAOONL|ncf10139970‏
996 ‎‡2 DNB|1192056558‏
996 ‎‡2 BLBNB|000354935‏
996 ‎‡2 SUDOC|264794710‏
996 ‎‡2 DNB|1108614159‏
996 ‎‡2 ISNI|0000000459325176‏
996 ‎‡2 NTA|154139904‏
996 ‎‡2 LC|n 2016257475‏
996 ‎‡2 ISNI|000000003494537X‏
996 ‎‡2 BLBNB|000471436‏
996 ‎‡2 RERO|A011431190‏
996 ‎‡2 NKC|mub20211104723‏
996 ‎‡2 LC|n 2011205432‏
996 ‎‡2 ISNI|0000000040450429‏
996 ‎‡2 ISNI|0000000045978572‏
996 ‎‡2 NSK|000675100‏
996 ‎‡2 LC|n 84116561‏
996 ‎‡2 ISNI|0000000068608240‏
996 ‎‡2 DNB|130496790‏
996 ‎‡2 RERO|A000144149‏
996 ‎‡2 NUKAT|n 2022063458‏
996 ‎‡2 DNB|1313255912‏
996 ‎‡2 ISNI|0000000069619435‏
996 ‎‡2 BNF|17085371‏
996 ‎‡2 SUDOC|20292663X‏
996 ‎‡2 ISNI|0000000068805594‏
996 ‎‡2 BLBNB|000628340‏
996 ‎‡2 DNB|113907413X‏
996 ‎‡2 BLBNB|000631226‏
996 ‎‡2 BLBNB|001452748‏
996 ‎‡2 ISNI|000000002658093X‏
996 ‎‡2 DNB|1060698358‏
996 ‎‡2 PTBNP|1650498‏
996 ‎‡2 PTBNP|210705‏
996 ‎‡2 ISNI|0000000069890057‏
996 ‎‡2 NSK|000493817‏
996 ‎‡2 LC|no2003060559‏
996 ‎‡2 LC|n 2023252681‏
996 ‎‡2 ISNI|0000000374167973‏
996 ‎‡2 BLBNB|001498059‏
996 ‎‡2 LC|no2009194754‏
996 ‎‡2 PTBNP|1559981‏
996 ‎‡2 PTBNP|1204247‏
996 ‎‡2 ISNI|0000000033179335‏
996 ‎‡2 PTBNP|284844‏
996 ‎‡2 LC|no2008180528‏
996 ‎‡2 LC|n 91041983‏
996 ‎‡2 PTBNP|175835‏
996 ‎‡2 BLBNB|000331132‏
996 ‎‡2 PTBNP|223058‏
996 ‎‡2 SUDOC|15189941X‏
996 ‎‡2 ISNI|000000006900334X‏
996 ‎‡2 NTA|072788313‏
996 ‎‡2 SUDOC|190625554‏
996 ‎‡2 NUKAT|n 2018249393‏
996 ‎‡2 BIBSYS|98049530‏
996 ‎‡2 DNB|1056486090‏
996 ‎‡2 LC|n 2015235803‏
996 ‎‡2 ISNI|000000003927451X‏
996 ‎‡2 ISNI|0000000069611994‏
996 ‎‡2 LC|n 2006212105‏
996 ‎‡2 PTBNP|1353039‏
996 ‎‡2 LC|no2021109503‏
996 ‎‡2 PTBNP|245368‏
996 ‎‡2 BLBNB|000537868‏
996 ‎‡2 PTBNP|1420037‏
996 ‎‡2 J9U|987007336034505171‏
996 ‎‡2 SUDOC|189557990‏
996 ‎‡2 CAOONL|ncf11491269‏
996 ‎‡2 SIMACOB|208398947‏
996 ‎‡2 LC|no2024076922‏
996 ‎‡2 J9U|987007386986505171‏
996 ‎‡2 ISNI|000000006880943X‏
996 ‎‡2 BNE|XX1033228‏
996 ‎‡2 ISNI|0000000081325974‏
996 ‎‡2 LC|n 2012202016‏
996 ‎‡2 PLWABN|9810558210105606‏
996 ‎‡2 BLBNB|000518221‏
996 ‎‡2 BLBNB|001461160‏
996 ‎‡2 ISNI|0000000024588962‏
996 ‎‡2 DNB|188435743‏
996 ‎‡2 LC|n 2006210716‏
996 ‎‡2 BLBNB|000361750‏
996 ‎‡2 BLBNB|000354966‏
996 ‎‡2 BNC|981058518234306706‏
996 ‎‡2 BLBNB|000184756‏
996 ‎‡2 NUKAT|n 2012258043‏
996 ‎‡2 LC|nb2009012612‏
996 ‎‡2 LC|no2002037734‏
996 ‎‡2 LC|n 82078821‏
996 ‎‡2 BLBNB|000493578‏
996 ‎‡2 ISNI|0000000068494028‏
996 ‎‡2 ISNI|0000000070195609‏
996 ‎‡2 ISNI|0000000081353262‏
996 ‎‡2 DNB|1137645350‏
996 ‎‡2 ISNI|0000000403458324‏
996 ‎‡2 ISNI|0000000050152409‏
996 ‎‡2 ISNI|0000000448126120‏
996 ‎‡2 ISNI|0000000036161931‏
996 ‎‡2 DNB|1330989864‏
996 ‎‡2 BLBNB|000985027‏
996 ‎‡2 LC|n 79032452‏
996 ‎‡2 LC|no2002051999‏
996 ‎‡2 ISNI|0000000434606596‏
996 ‎‡2 BLBNB|000548257‏
996 ‎‡2 PTBNP|244624‏
996 ‎‡2 LC|n 2011214830‏
996 ‎‡2 BLBNB|000354970‏
996 ‎‡2 LC|no2005045789‏
996 ‎‡2 ISNI|0000000045388185‏
996 ‎‡2 LC|n 78030918‏
996 ‎‡2 LC|n 94018358‏
996 ‎‡2 SUDOC|143415530‏
996 ‎‡2 LC|n 84153983‏
996 ‎‡2 PTBNP|1051804‏
996 ‎‡2 DNB|105297712X‏
996 ‎‡2 BLBNB|001578435‏
996 ‎‡2 BLBNB|000473466‏
996 ‎‡2 ISNI|0000000382247981‏
996 ‎‡2 ISNI|0000000079987127‏
996 ‎‡2 NTA|323253903‏
996 ‎‡2 ISNI|0000000063718141‏
996 ‎‡2 BIBSYS|1579001847767‏
996 ‎‡2 LC|n 89100941‏
996 ‎‡2 BLBNB|000513882‏
996 ‎‡2 SUDOC|268498210‏
996 ‎‡2 ISNI|0000000390636362‏
996 ‎‡2 DNB|1060680491‏
996 ‎‡2 NTA|408055952‏
996 ‎‡2 BLBNB|001511737‏
996 ‎‡2 ISNI|0000000026972992‏
996 ‎‡2 PTBNP|167629‏
996 ‎‡2 BLBNB|000355238‏
996 ‎‡2 ISNI|0000000069501779‏
996 ‎‡2 BIBSYS|10005428‏
996 ‎‡2 PTBNP|1874214‏
996 ‎‡2 ISNI|0000000044536019‏
996 ‎‡2 BLBNB|000556190‏
996 ‎‡2 DNB|138166323‏
996 ‎‡2 PLWABN|9811275814605606‏
996 ‎‡2 ISNI|0000000068685641‏
996 ‎‡2 LC|no2015065993‏
996 ‎‡2 ISNI|0000000052132030‏
996 ‎‡2 PTBNP|1552506‏
996 ‎‡2 DNB|1268673315‏
996 ‎‡2 ISNI|0000000052006587‏
996 ‎‡2 NDL|031968684‏
996 ‎‡2 LC|n 2022041992‏
996 ‎‡2 RERO|A020162737‏
996 ‎‡2 W2Z|1579001847767‏
996 ‎‡2 ISNI|0000000067227171‏
996 ‎‡2 BLBNB|000288221‏
996 ‎‡2 PTBNP|38754‏
996 ‎‡2 ISNI|0000000036161659‏
996 ‎‡2 LC|nr2004024328‏
996 ‎‡2 DNB|1056716193‏
996 ‎‡2 DNB|131464027‏
996 ‎‡2 ISNI|0000000115755834‏
996 ‎‡2 LC|n 2007206725‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏